CClinicalTrials.gg
Not yet recruitingNCT06896955Updated Mar 26, 2025

Effects of Virtual Reality Application and Progressive Relaxation Exercise

An interventional study of PMR+VR Education and PMR Education in Pregnancy, Exercise and Virtual Reality, sponsored by Cukurova University. Not yet recruiting at 1 site in Turkey. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-26.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 1 month ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

In the study, random assignment and randomization concealment will be applied to control selection bias. Pregnant women were assigned to groups by an independent statistician using the block randomization method. For this purpose, 6-digit combinations consisting of the letters "A", "B" and "C" were first created in the randomization of 78 women.

Read the detailed description

There will be three groups in the randomized experimental controlled study:PRE (Progressive Relaxation Exercise), VR (Virtual Reality)+PGR (Progressive Relaxation Exercise) and Control group. In order to carry out the application phase of the study, the responsible researcher participated in the training program on PRE and received a certificate on this subject. In addition, permission for the use of PRE Cd was obtained from the Turkish Psychologists Association to be used in the PRE group. The following procedures will be performed for pregnant women included in the study.

02

Conditions studied

  • Pregnancy
  • Exercise
  • Virtual Reality

Keywords

  • Pregnancy
  • Exercise
  • progressive exercise
  • virtual reality
03

In context

Lead sponsor

Cukurova University is the lead sponsor of 247 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Voluntary participation
  • No communication difficulties (no mental retardation, no visual/hearing impairment)
  • Knowing Turkish and being literate
  • No fetal anomalies
  • Being in the 32nd week of pregnancy
  • Not being diagnosed with a risky pregnancy (multiple pregnancy, premature rupture of membranes, preeclampsia, gestational diabetes, placenta previa, etc., pregnancies may end with a cesarean section)

Exclusion criteria

Exclusion Criteria:

  • Having a psychiatric disease diagnosis
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    PMR Group

    * After meeting the pregnant woman in the polyclinic, a personal information form and the Pregnancy Stress Assessment Scale will be filled out at the beginning of the research. * PMR will be explained to the pregnant woman and the first application will be done together. Any questions the pregnant woman may have will be answered. * An education booklet will be given about PMR. * The application will be performed 3 times a week starting at the 32nd week of pregnancy until labor begins, each application lasting 20 minutes. * The first application will be done face to face, and subsequent applications will be done by the pregnant woman herself, accompanied by a PMRvideo. * Continuous communication will be maintained with the pregnant woman via mobile phone. * The Pregnancy Stress Assessment Scale will be filled out at the 38th week. * The Birth Affect Scale and Birth Self-Efficacy Scale will be filled out on the first day after birth.

    Other: PMR Education

  • Experimental
    VR+PMR Group

    * PMR will be applied to this group accompanied by a therapeutic video shown with virtual reality glasses. * At the beginning of the research, a personal information form and the Pregnancy Stress Assessment Scale will be filled out. * An educational booklet about PMR will be given. * After both application methods are shown and applied, PGE will be applied together accompanied by a therapeutic video shown with virtual reality glasses. * The application will be performed 3 times a week starting from the 32nd week of pregnancy until labor begins, 20 minutes each time. * The first application will be done face to face, and subsequent applications will be done by the pregnant woman herself. * Pregnancy Stress Assessment Scale will be filled out again in the 38th week. * On the first day after delivery, the Birth Affect Scale, Birth Self-Efficacy Scale and Virtual Reality Glasses Application Evaluation Form will be filled out.

    Other: PMR+VR Education

  • No intervention
    Control Group

    * Pregnant women in the control group will not be subjected to any treatment other than routine pregnancy follow-up and examinations at the hospital. * Forms will be filled out in parallel with the intervention groups. * Participants who wish will be given an educational booklet about PGE at the end of the study.

Interventions

  • OtherPMR+VR Education

    PMR and VR education

  • OtherPMR Education

    PMR education

06

What researchers measure

Primary outcomes

  1. Pregnancy Stress Assessment Scale

    Change in pregnancy-related stress levels in pregnant women. As the score from the scale increases, stress increases.

    Time frame: pre-intervention, after 2 month

  2. Birth Self-Efficacy Scale

    Change in self-efficacy levels of pregnant women during labor. As the score from the scale increases, self-efficacy increases.

    Time frame: intervention after 2 month

  3. Birth Affect Scale

    Change in the emotional state experienced by mothers during labor. As the score from the scale increases, positive affect increases.

    Time frame: intervention after 2 month

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06896955
Lead sponsor
Cukurova University
Responsible party
Sule Gokyildiz Surucu (Sule Gokyildiz Surucu, Cukurova University) — Principal investigator
First posted
Mar 26, 2025
Start date
Mar 25, 2025 (estimated)
Primary completion
Aug 25, 2025 (estimated)
Completion
Mar 25, 2026 (estimated)
Last update
Mar 26, 2025

Study contacts

Sule Gokyildiz Surucu, Prof.
Contact
gokyildizsurucu@gmail.com
+90 (322) 338 64 84 ext. 1161
Senay Dagilgan, Msc
Contact
sdagilgan@cu.edu.tr
+90 (322) 338 65 38 ext. 136
Senay Dagilgan, Msc
principal investigator · Cukurova University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion